YRT-97452-61315
2 vaccinations
2 coded responses
9 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 760 / TX
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-10
Dose 1 — Moderna
-
2021-02-12
Registered in v-safe
- 2021-02-13
-
2021-02-15
Survey response — days 1–6 daily, dose 1MedDRA: Epistaxis — Feeling: GoodFree text: Mild symptom of Small amount of blood-tinged mucus when blowing my nose. Not usual unless I have experienced sinus infection. However, it is not acute illness or bothersome in any way.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-17
-
2021-02-24
Survey response — day 14, dose 1MedDRA: Injection site pruritus, Injection site rash — Feeling: GoodFree text: I developed a rash to the vaccination site on the day I submitted the last check-in, which was a week. It was a large area around the site of insertion and it was itchy. However, it is resolving. I took some Benadryl. No other issues.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
-
2021-03-10
Dose 2 — Moderna
- 2021-03-17
- 2021-03-26
- 2021-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Moderna | |
| 2 | 2021-03-10 | Moderna |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Mild symptom of Small amount of blood-tinged mucus when blowing my nose. Not usual unless I have experienced sinus infection. However, it is not acute illness or bothersome in any way.
Release 4 — day 14, dose 1
Symptoms: I developed a rash to the vaccination site on the day I submitted the last check-in, which was a week. It was a large area around the site of insertion and it was itchy. However, it is resolving. I took some Benadryl. No other issues.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SRO | Epistaxis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release